Gross G,Wicke K,Drescher KU.Dopamine D3receptor antagonism-still a therapeutic option for the treatment of schizophrenia[J].Naunyn Schmiedebergs Arch Pharmacol,2013,386:S155-S166.
[2]
Jha MK,Minhajuddin A,Gadad BS,et al.Platelet-derived growth factor as an antidepressant treatment selection biomarker:higher levels selectively predict better outcomes with bupropion-SSRI combination[J].Neuropsychopharmacol,2017,20(Suppl 11):S919-S927.
[3]
DeWilde KE,Levitch CF,Murrough JW,et al.The promise of ketamine for treatment-resistant depression:current evidence and future directions[J].Ann N Y Acad Sci,2015,1 345:S47-S58.
[4]
Singh R,Mazi-Kotmal N,Thalitaya MD.Recognising and Treating Depression in the Elderly[J].Psychiatr Danub,2015,27(Suppl 1):S231-S234.
[5]
Wilkinson ST,Wright D,Fasula MK,et al.Cognitive behavior therapy may sustain antidepressant effects of intravenous ketamine in treatment-resistant depression[J].Psychother Psychosom,2017,86(Suppl 3):S162-S167.
[6]
Szebeni A,Szebeni K,DiPeri TP,et al.Elevated DNA Oxidation and DNA Repair Enzyme Expression in Brain White Matter in Major Depressive Disorder[J].Int J Neuropsychopharmacol,2017,20(Suppl 5):S363-S373.
[7]
Foti D,Carlson JM,Sauder CL,et al.Reward dysfunction in major depression:multimodal neuroimaging evidence for refining the melancholic phenotype[J].Neuroimage,2014,101:S50-S58.
[8]
Franken IHA,Rassin E,Muris P.The assessment of anhedonia in clinical and non-clinical populations:further validation of the Snaith-Hamilton Pleasure Scale(SHAPS)[J].Affect Disord,2007,99:S83-S89.
[9]
Zoratto F,Fiore M,Ali SF,et al.Neonatal tryptophan depletion and corticosterone supplementation modify emotional responses in adult male mice[J].Psychoneuroendocrinology,2013,38(Suppl 1):S24-S39.
[10]
Kelly JR,Borre YCOB,Patterson E,et al.Transferring the blues:Depression-associated gut microbiota induces neurobehavioural changes in the rat[J].Psychiatr Res,2016,82:S109-S118.
[11]
Tobias B,Helge H,Werner S,et al.White matter microstructure alterations of the medial forebrain bundle in melancholic depression[J].Journal of Affective Disorders,2014,155:S186-S193.
[12]
Sarah EH,Ana IV,Benjamin AE,et al.The neural correlates of emotional face-processing in adolescent depression:a dimensional approach focusing on anhedonia and illness severity[J].Psychiatry Research:Neuroimaging,2014,224:S234-S241.
[13]
Takamura M,Okamoto Y,Okada G,et al.Patients with major depressive disorder exhibit reduced reward size coding in the striatum[J].Prog Neuropsychopharmacol Biol,2017,79:S317-S323.
[14]
Yang XH,Tian K,Wang DF,et al.Anhedonia correlates with abnormal functional connectivity of the superior temporal gyrus and the caudate nucleus in patients with first-episode drug-naive major depressive disorder[J].Affect Disord,2017,218:S284-S290.
[15]
Parvaz MA,Gabbay V,Malaker P,et al.Objective and specific tracking of anhedonia via event-related potentials in individuals with cocaine use disorders[J].Drug Alcohol Depend,2016,164:S158-S165.
[16]
Llerena K,Park SG,McCarthy JM,et al.The Motivation and Pleasure Scale-Self-Report(MAP-SR):reliability and validity of a self-report measure of negative symptoms[J].Compr Psychiatry,2013,54(Suppl 5):S568-S574.
[17]
Lapidus VG,Xiangling M,Amy J,et al.In vivo 1 H MRS study of potential associations between glutathione,oxidative stress and anhedonia in major depressive disorder[J].Neuroscience Letters,2014,569:S74-S79.
[18]
Rmer Thomsen K,Whybrow PC,Kringelbach ML.Reconceptualizing anhedonia:novel perspectives on balancing the pleasure networks in the human brain[J].Front Behav Neurosci,2015:9:49.
[19]
Pecina M,Sikora M,Avery ET,et al.Striatal dopamine D2/3receptor-mediated neurotransmission in major depression:Implications for anhedonia,anxiety and treatment response[J].Eur Neuropsychopharmacol,2017,27(10):977-986.
[20]
Pardo M,Lopez-Cruz L,San Miguel N,et al.Selection of sucrose concentration depends on the effort required to obtain it:studies using tetrabenazine,D1,D2,and D3receptor antagonists[J].Psychopharmacology(Berl),2015,232(Suppl 13):S2 377-S2 391.
[21]
Van Heesch F,Prins J,Konsman JP,et al.Lipopolysaccharide-induced anhedonia is abolished in male serotonin transporter knockout rats:an intracranial selfstimulation study[J].Brain Behav Immun,2013,29:S98-S103.
[22]
Medel-Matus JS,Shin D,Sankar R,et al.Inherent vulnerabilities in monoaminergic pathways predict the emergence of depressive impairments in an animal model of chronic epilepsy[J].Epilepsia,2017,58(Suppl8):S116-S121.
[23]
Tang M,He T,Sun X,et al.Subregion-specific decreases in hippocampal serotonin transporter protein expression and function associated with endophenotypes of depression[J].Hippocampus,2014,24(Suppl 4):S493-S501.
[24]
Sayd A,Anton M,Alen F,et al.Systemic administration of oleoylethanolamide protects from neuroinflammation and anhedonia induced by LPS in rats[J].Int J Neuropsychopharmacol,2014,18(Suppl 6):S111.
[25]
Wise RA.Dopamine and reward:the anhedonia hypothesis 30years on[J].Neurotox Res,2008,14:S169-S183.
[26]
Treadway MT,Zald DH.Reconsidering anhedonia in depression:lessons from translational neuroscience[J].Neurosci Biobehav Rev,2011,35(Suppl 3):S537-S555.
[27]
Poulin JF,Laforest S,Drolet G.Enkephalin downregulation in the nucleus accumbens underlies chronic stress-induced anhedonia[J].Stress,2014,17(Suppl1):S88-S96.
